Our studies identify a heightened C3aR/HIF-1α signaling axis that influences microglial metabolic and lipid homeostasis in Alzheimer disease, suggesting that targeting this pathway may offer therapeutic benefit. The gene discussed is HIF1A; the disease is early-onset autosomal dominant Alzheimer disease.